IDEAYA Biosciences, Inc. (IDYA) Financials

IDYA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 649.3 million 28.2 million
2023-09-30 532.9 million 24.9 million
2023-06-30 527.6 million 527.6 million
2023-03-31 364.7 million 364.7 million

IDYA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -24.6 million 4.8 million
2023-09-30 -30.8 million 5.3 million
2023-06-30 -34.3 million 4.7 million
2023-03-31 -27.9 million 3.7 million

IDYA Net Income

No data available :(

IDYA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 632.6 million - 2.9 million
2023-09-30 511.1 million - 2.1 million
2023-06-30 510.1 million - 2.6 million
2023-03-31 351.2 million - 3.0 million

IDYA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 65.2 million
2023-09-30 60.0 million
2023-06-30 56.3 million
2023-03-31 48.4 million

IDYA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 838000 38.8 million 7.1 million 1000
2023-09-30 603000 33.7 million 7.9 million -
2023-06-30 884000 29.2 million 7.1 million -
2023-03-31 43000 27.9 million 6.3 million -

IDYA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 3.9 million 1.0 million
2023-09-30 8.0 million 986000
2023-06-30 3.5 million 998000
2023-03-31 7.9 million 960000

IDYA

Price: $42.21

52 week price:
13.55
47.74

Earnings Per Share: -1.96 USD

P/E Ratio: -23.10

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 546053

Market Capitalization: 3.2 billion

Links: